V116 Well-Tolerated With Broad Immune Responses in Pneumococcal Vaccine-Naïve Older Adults
Pharmacy Times
AUGUST 12, 2025
The vaccine showed superior immune response for unique serotypes compared to PPSV23, with higher OPA titers.
2022 Compounding Immunization 
Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry
PharmaTech
JUNE 10, 2025
s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. Washington, DC, USA - June 24, 2022: The symbol of the U.S. Kennedy Jr. Press Release.
Join 11,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Actithera draws new investors to radiopharma drug pitch
BioPharma Dive
JULY 9, 2025
The technology works by attaching a radioisotope to a targeting compound via a specially engineered “linker” molecule. billion since 2022 from a group of 23 venture firms tracked by BioPharma Dive. It’s a way to dismantle a critical barrier to immune and therapeutic access,” he wrote in an email to BioPharma Dive.
Lipid-Lowering Effects Discovered in FDA-Approved Drugs Using Machine Learning
Pharmacy Times
AUGUST 9, 2025
prevalence of hypercholesterolemia and about a quarter of US adults harbored elevated low-density lipoprotein cholesterol (LDL-C) levels from 2017 to 2022. The American Heart Association’s 2023 Heart Disease and Stroke Statistics Update found a 34.7%
FDA Mandates Major Opioid Label Revisions to Highlight Long-Term Risks
Pharmacy Times
AUGUST 7, 2025
Expanded warnings include interactions with CNS depressants and rare outcomes like esophageal dysfunction, aligning with CDC's 2022 opioid prescribing guidelines. Labels now emphasize the risks of higher doses and caution against abrupt discontinuation in dependent patients to prevent withdrawal and other harms.
The Changing Landscape of Pharmacy Accessibility
Pharmacy Times
JULY 22, 2025
Image Credit: Elena | stock.adobe.com A 2022 study reported that approximately 90% of the United States population lives within 5 miles of a pharmacy. 1 Unfortunately, the recent trend of pharmacy closures threatens equitable access to health care.
Antidiabetic Medication Combinations Have Varying Effects on Diabetic Kidney Disease Progression
Pharmacy Times
AUGUST 8, 2025
KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473-1478. doi:10.2337/dc08-0545 Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. Kidney Int. 2022;102(5S):S1-S127. doi:10.1016/j.kint.2022.06.008
Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season
Pharmacy Times
JULY 21, 2025
Reduced immunity from COVID-19 precautions and low vaccination rates, especially among children and vulnerable groups, worsened the influenza season's impact. Systemic inequities, misinformation, and geographic disparities hindered vaccination efforts, with significant coverage gaps among racial and rural populations.
COVID-19 Pandemic Reduced Gaps in Pneumococcal Vaccination in Medicare Enrollees, But Lowered Overall Uptake
Pharmacy Times
JULY 25, 2025
According to 2022 data from a National Health Interview Survey of US adults ages 18 and older, just 23.0% Despite their purported efficacy and safety, uptake remains below target levels. of individuals ages 19 to 64 at increased risk for pneumococcal disease and 64.0%
Study Reveals Gaps in GINA Guideline Adherence for Asthma Treatment
Pharmacy Times
JUNE 9, 2025
Study Overview Researchers conducted a retrospective chart review of 80 patients aged 12 or older within Intermountain Health who were diagnosed with asthma between December 2022 and December 2023. To ensure continuity of care, patients included had seen a primary care provider both in the year prior to and following their diagnosis.
Pharmacists Push Forward: Innovative Clinical Solutions Highlighted at McKesson ideaShare 2025
Pharmacy Times
JULY 12, 2025
4 Novak added that these services align well with appointment-based models and can be layered with immunizations, chronic disease monitoring, and medication therapy management. Addressing Barriers and Finding Solutions Despite the promise of these services, challenges remain.
Transitions of Care Pharmacists Mitigate Readmission Rates for COPD
Pharmacy Times
JUNE 23, 2025
Its average fiscal year 2022 readmission rate was 23.7%, exceeding the 19.6% The Centers for Medicare & Medicaid Services (CMS) includes AECOPD as 1 of the 6 conditions in the Hospital Readmissions Reduction Program (HRRP), signaling a significant focus on reducing this cause of readmission. HRRP benchmark.
IsaKRD Induction Achieves 95% Response Rate in Multiple Myeloma
Pharmacy Times
JULY 8, 2025
May 4, 2022. Multiple myeloma. Cleveland Clinic. Accessed July 8, 2025. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!
Hypertension: A Silent Killer Requiring Novel Therapies
Pharmacy Times
JULY 19, 2025
Lancet 2022; 400:1927-1937. Cardiol and Therapy 2021;10:397-406. doi:10.1007/s40119-021-00233-7 Schlaich M, Bellet M, Weber M, et al. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial. Radner, PA: Idorsia Pharmaceuticals US, Inc; 2025 April.
Secondary Analysis Investigates Spillover Effects of Antibiotic Audit and Feedback
Pharmacy Times
JULY 16, 2025
The trial was conducted from January 2021 to December 2022, with a feedback letter sent on or after January 2022, including physicians that were randomly assigned in a 4 to 1 allocation. The misuse and overuse of antimicrobials to treat, prevent, and control infections has influenced the spread of AMR.
A Review of Oral Cephalosporins for Common Outpatient Infections
Pharmacy Times
JULY 25, 2025
Updated September 21, 2022. Arthritis Care Res ( Hoboken ). 2021;73(1):1-9. doi:10.1002/acr.24495. Gonococcal Infections Among Adolescents and Adults. Centers for Disease Control and Prevention. Accessed March 5, 2025.
Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement
Pharmacy Times
JUNE 23, 2025
In 2022, CMS reevaluated 505(b)(2) drugs in relation to section 1847A of the Social Security Act (SSA). In 2022, based upon a complaint filed by a pharmaceutical company, CMS was asked to reevaluate the SSA section that establishes the J-code,” Soefje said. That has changed based upon the [recent] CMS ruling.”
Because Ned Said: New Technology Helps Prevent Opioid Overdose
Pharmacy Times
JUNE 9, 2025
Abuse Deterrent Pharma, LLC (ADP), has licensed the LIMITX technology from Acura Pharmaceuticals for a number of pharmaceutical compounds. trillion economic impact in 2020. trillion economic impact in 2020. However, a new advancement in the marketplace is intended to prevent potential injury or death.
Invest a Few Minutes in Inhaler Counseling
Pharmacy Times
JULY 23, 2025
link] 2022 global strategy for prevention, diagnosis, and management of COPD. Updated 2022. Lancet Respir Med.2022;10(5):447-458. 2022;10(5):447-458. doi:10.1016/S2213-2600(21)00511-7 Global strategy for asthma management and prevention. Accessed June 6,2025. Global Initiative for Asthma. Accessed June 6, 2025.
Zanubrutinib Linked to Lower Infection Risk Than Venetoclax Plus Obinutuzumab in Real-World CLL/SLL Study
Pharmacy Times
JULY 9, 2025
However, patients with CLL/SLL typically have a higher risk of serious infection due to their compromised immune systems, raising concerns about the association between CLL/SLL-directed therapies and serious infection risks.
Researchers Evaluate Infection Control Challenges During an RSV Outbreak in a Cognitively Impaired Population
Pharmacy Times
AUGUST 7, 2025
1 RSV Outbreak in Long-Term Care Facility Researchers assessed the RSV outbreak that occurred in a long-term care facility in 2022 to identify successful strategies that other facilities can apply in similar situations.
Breaking New Ground in Migraine Prevention: Eptinezumab-jjmr
Pharmacy Times
JULY 2, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
Managing Tardive Dyskinesia With VMAT2 Inhibitors in Clinical Practice
Pharmacy Times
JULY 28, 2025
American Psychiatric Publishing; 2022. Cambridge University Press; 2013:129-236. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed, text revision. Keepers GA, Fochtmann LJ, Anzia JM, et al. The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia.
CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies
Pharmacy Times
JUNE 19, 2025
Development Trends: Oncology at the Forefront Gene therapy currently ranks third among therapeutic focus areas, with 2151 compounds in development in 2024 ( Figure ). 2-4 In the United States, the FDA had approved 44 cell therapy products as of March 6, 2025. 6 CAR T-cell therapies continue to dominate the genetically modified space.
New Online Competency Modules Standardize CPA Pharmacist Training at Academic Medical Center
Pharmacy Times
JUNE 9, 2025
Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes: An umbrella review. Res Social Admin Pharm. 2020;16(9):1155-1165. doi:10.1016/j.sapharm.2019.12.016 2019.12.016 3. ASHP Statement on Professionalism. American Society of Health-System Pharmacists. Accessed June 9, 2025.
Study Confirms Interchangeability of Hulio, Biosimilar of Humira, in Severe Chronic Plaque Psoriasis
Pharmacy Times
JUNE 24, 2025
Patients were enrolled from 31 sites across 4 countries between December 5, 2022, and September 19, 2023. Adalimumab received its initial approval from the FDA for the treatment of rheumatoid arthritis. 3 The trial’s primary objective was to evaluate the interchangeability of low-concentration Hulio (40 mg/0.8
FDA Moves to Restrict 7-OH Opioid Products
Pharmacy Times
AUGUST 6, 2025
FDA recommends 7-OH compound found in vapes be controlled. Published March 25, 2022. FDA file:///Users/daniellevalletti/Downloads/7-hydroxymitragynin_7-oh_an_assessment_of_the_scientific_data_and_toxicological_concerns_around_an_emerging_opioid_threat%20(1).pdf Reuters Staff. link] Published July 29, 2025. Accessed August 6, 2025.
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
Pharmacy Times
JULY 10, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)
TAR-200 Clears Tumors in 82% of Patients With BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer
Pharmacy Times
AUGUST 13, 2025
August 31, 2022. Goldberg IP, Lichtbroun B, Singer EA, Ghodoussipour S. Pharmacologic Therapies for Non-Muscle Invasive Bladder Cancer: Current and Future Treatments. Arch Pharmacol Ther. PMCID: PMC9431226 3. New treatment eliminates bladder cancer in 82% of patients. News Release. August 13, 2025. Accessed August 13, 2025.
Pharmacists' Guide to Selection and Use of At-Home Blood Pressure Monitors
Pharmacy Times
JULY 30, 2025
In 2022, HTN was cited as a primary or contributing cause of 685,875 deaths in the United States. According to the CDC, HTN is defined as consistent readings of systolic blood pressure greater than 130 mm Hg or a diastolic blood pressure greater than 80 mm Hg.1 1 According to CDC data, an estimated 48.1% million individuals.
OTC Assessments With Recommendations and Counseling Should Be a Billable Encounter
Pharmacy Times
JUNE 17, 2025
OTC Use Saves Billions From Cost-Effective Products and Encounters Image credit: Amina | stock.adobe.com A 2022 publication purported $167 billion in savings in ancillary health care cost avoidance through the widespread use of OTC products in the United States.
ADA 2025: Advances in Type 2 Diabetes Management With Tirzepatide
Pharmacy Times
JUNE 23, 2025
1 Clinical Data for Tirzepatide Mechanism of Action Tirzepatide was approved by the FDA in May 2022 for adults with T2D to improve glycemic control, in conjunction with diet and exercise. Fonseca highlighted recent shifts in ADA and ACE guidelines that prioritize early and sustained weight loss as a strategy to prevent complications.
Ropeginterferon Alfa 2b Is Well-Tolerated, Efficacious in Treatment of Prefibrotic Myelofibrosis
Pharmacy Times
JUNE 30, 2025
Updated October 6, 2022. Anemia (grade 1–2: n = 15, 21.1%; grade 3–4: n = 6, 8.5%), neutropenia (grade 1–2: n = 15, 21.1%; grade 3–4: n = 4, 5.6%) and thrombocytopenia (grade 1–2: n = 8, 11.2%; grade 3–4: n = 3, 4.2%) were the most common hematologic AEs. Continued study is needed to further elucidate the results of the study. REFERENCES 1.
Mitomycin Intravesical Solution Receives FDA Approval for Non-Muscle Invasive Bladder Cancer
Pharmacy Times
JUNE 12, 2025
November 16, 2022. Accessed June 12, 2025. Deng S, Meng F, Wang L, et al. Global research trends in non-muscle invasive bladder cancer: Bibliometric and visualized analysis. Front Oncol. doi:10.3389/fonc.2022.1044830 2022.1044830 3. Prasad SM, Shishkov D, Mihaylov NV, et al.
Op-Ed: Celebrate Direct-to-Career Paths and Primary Care Pharmacy Practice
Pharmacy Times
JUNE 10, 2025
North American Pharmacist Licensure Examination Passing Rates for 2022-2024 Graduates. Accreditation Standards and Key Elements for the Professional Program in Pharmacy Leading to the Doctor of Pharmacy Degree. July 1, 2024. Accessed June 6, 2025. National Association of Boards of Pharmacy. January 21, 2025. Accessed June 6, 2025.
Psychiatric Medication Adherence in Patients Experiencing Homelessness
Pharmacy Times
JULY 17, 2025
Reviewing Medication Adherence According to the WeAllCount Census for 2022 to 2023, 6 homelessness in San Diego increased by 22% (from 8427 to 10,264 individuals).
FDA Approves Twice-Yearly Lenacapavir for HIV Preexposure Prophylaxis
Pharmacy Times
JUNE 18, 2025
In 2022, it received approval from the FDA for patients with HIV-1 infection in heavily treatment-experienced (HTE) adults with multi-drug resistant (MDR) infection. These processes allowed for lenacapavir to have an expedited review process due to the substantial improvements it could make compared with currently available therapies.
Do We Really Pay More for Prescription Drugs in the United States?
Pharmacy Times
JUNE 12, 2025
Biden’s 2022 Inflation Reduction Act (IRA), creating an out-of-pocket spending cap of $2000 starting in 2025, and Part D has become a very generous pharmacy benefit. From a coverage perspective, Part D has been a success, with older Americans paying far less for drugs than they otherwise would have prior to MMA 2003. Add President Joseph R.
Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics
PharmaTech
JUNE 24, 2025
Some companies are combining mRNA vaccines with programmed cell death protein 1 (PD-1) inhibitors to activate the immune system and elicit tumour-specific T-cell responses. In 2022, the company raised €39 million in a series B round that included the participation of Chien and Dekkers, co-founders of Dropshot Therapeutics.
Can Cilta-Cel Redefine Outcomes in Multiple Myeloma?
Pharmacy Times
AUGUST 6, 2025
The goal is to harness a patient’s immune system to recognize and target cancer cells, offering better sensitivity and specificity, limiting damage to healthy cells, and personalizing treatment. It increases patients’ survival and quality of life.
NHC Responds to Joint CMS–ASTP/ONC RFI on Improving Health Technology
Putting Patients First Blog
JUNE 16, 2025
For example, incorporating immunization registries, social service data, and SDOH risk factors from trusted third-party sources would support holistic patient engagement tools. 2] These challenges are compounded in rural and underserved areas, where access to broadband and support infrastructure may be limited. [3] 10 (2022): 1940.
Is Fluoride Friend or Foe?
Pharmacy Times
JUNE 25, 2025
2022 water fluoridation statistics. The agency has set a date of October 31, 2025, to discuss the safety review and public comments. 8 It seems certain that key organizations and oral health professionals will advocate against these policy shifts. Regardless, this matter will continue to generate debate. REFERENCES 1. June 6, 2024.
Patients Allege Home Delivery Pharmacy Failed Timely Notification of Data Breach
Pharmacy Times
JUNE 24, 2025
Image credit: neirfy | stock.adobe.com In February 2022, 9 months after the initial discovery and 13 months after the breach, the pharmacy began notifying customers of a breach in its computer information. Personally identifiable information (PII), including names and Social Security numbers for more than 75,000 customers, was breached.
ASCO 2025: Promising Safety and Efficacy of Encorafenib and Binimetinib in Resected Stage II Melanoma
Pharmacy Times
JUNE 9, 2025
1 Following this, the investigators screened 339 individuals for a BRAF mutation between June 2022 and October 2023 before randomly assigning 110 individuals to receive either enco+bini or placebo arms.
Let's personalize your content